home / stock / aps:cc / aps:cc quote
Last: | $0.93 |
---|---|
Change Percent: | -5.1% |
Open: | $0.98 |
Close: | $0.98 |
High: | $0.98 |
Low: | $0.91 |
Volume: | 17,948 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.93 | $0.98 | $0.98 | $0.98 | $0.91 | 17,948 | 08-02-2022 |
$1.51 | $1.52 | $1.51 | $1.53 | $1.45 | 51,523 | 05-06-2022 |
$1.57 | $1.5 | $1.57 | $1.57 | $1.46 | 64,334 | 05-05-2022 |
$1.52 | $1.55 | $1.52 | $1.55 | $1.44 | 38,848 | 05-04-2022 |
$1.54 | $1.51 | $1.54 | $1.56 | $1.51 | 16,111 | 05-03-2022 |
$1.52 | $1.53 | $1.52 | $1.53 | $1.46 | 12,175 | 05-02-2022 |
$1.5 | $1.52 | $1.5 | $1.52 | $1.46 | 22,510 | 04-29-2022 |
$1.47 | $1.49 | $1.47 | $1.5 | $1.45 | 13,231 | 04-28-2022 |
$1.44 | $1.47 | $1.44 | $1.52 | $1.44 | 25,867 | 04-27-2022 |
$1.46 | $1.54 | $1.46 | $1.54 | $1.44 | 34,196 | 04-26-2022 |
$1.46 | $1.46 | $1.46 | $1.49 | $1.42 | 68,212 | 04-25-2022 |
$1.46 | $1.47 | $1.46 | $1.47 | $1.39 | 32,972 | 04-22-2022 |
$1.44 | $1.53 | $1.44 | $1.53 | $1.42 | 63,944 | 04-21-2022 |
$1.46 | $1.49 | $1.46 | $1.51 | $1.46 | 100,865 | 04-20-2022 |
$1.52 | $1.52 | $1.52 | $1.55 | $1.48 | 71,145 | 04-19-2022 |
$1.51 | $1.59 | $1.51 | $1.59 | $1.46 | 55,261 | 04-18-2022 |
$1.58 | $1.58 | $1.58 | $1.6 | $1.56 | 21,589 | 04-15-2022 |
$1.58 | $1.58 | $1.58 | $1.6 | $1.56 | 21,527 | 04-14-2022 |
$1.6 | $1.57 | $1.6 | $1.63 | $1.57 | 26,577 | 04-13-2022 |
$1.61 | $1.66 | $1.61 | $1.7 | $1.56 | 62,026 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Aptose Biosciences Inc. Company Name:
APS:CC Stock Symbol:
TSXC Market:
SAN DIEGO and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, will report financial results for the first quarter ended...
A look at the top 10 most actives in Canada Reunion Gold Corporation (RGD) rose 3.3% to $0.62 on volume of 19,634,224 shares Enbridge Inc. (ENB) fell 0.0% to $48.41 on volume of 16,783,668 shares Desjardins American Equity Index ETF (DMEU) rose 0.6% to $19.88 on volume of 14,439,093 share...
Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML Tuspetinib Continues Broad Activity Across Mutations with Excellent Safety Profile Luxeptinib G3 Formulation Achieves Desired Levels and Positions for Future Trials Conference Call ...